Mauro Gitto
Overview
Explore the profile of Mauro Gitto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
394
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gitto M, Sartori S, Vogel B, Leone P, Smith K, Bay B, et al.
Can J Cardiol
. 2025 Mar;
PMID: 40058732
Background: Patients with cancer undergoing percutaneous coronary intervention (PCI) experience higher risk of both ischemic and bleeding events. The aim of this study is to assess ischemic and bleeding risks...
2.
Di Muro F, Sartori S, Vogel B, Feng Y, Gitto M, Oliva A, et al.
Clin Res Cardiol
. 2025 Feb;
PMID: 39998662
Background: Chronic kidney disease (CKD) is associated with unfavorable outcomes in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). However, its prognostic role in patients undergoing complex...
3.
Kunadian V, Gitto M, Vogel B, Sartori S, Angiolillo D, Bhatt D, et al.
JACC Cardiovasc Interv
. 2025 Feb;
PMID: 39969452
Background: In patients at high bleeding risk (HBR), short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is associated with reduced bleeding and preserved ischemic protection. Objectives: The aim...
4.
Bay B, Gitto M, Sartori S, Vogel B, Tchetche D, Petronio A, et al.
Catheter Cardiovasc Interv
. 2025 Jan;
105(4):891-899.
PMID: 39776285
Background: Limited data exist on the impact of polyvascular disease (PolyVD) on clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate clinical outcomes...
5.
Sartore L, Gitto M, Oliva A, Kakizaki R, Mehran R, Raber L, et al.
Rev Cardiovasc Med
. 2025 Jan;
25(12):433.
PMID: 39742224
In-stent restenosis (ISR) remains the predominant cause of stent failure and the most common indication for repeat revascularization. Despite technological advances in stent design, ISR continues to pose significant challenges,...
6.
Gao M, Spirito A, Sartori S, Vogel B, Gitto M, Oliva A, et al.
Catheter Cardiovasc Interv
. 2024 Dec;
105(3):681-691.
PMID: 39718124
Background: Whether the high bleeding risk (HBR) criteria of the Academic Research Consortium (ARC) have a consistent predictive ability across different categories of body mass index (BMI) remains unclear. Methods:...
7.
Gitto M, Gilhooley S, Smith K, Vogel B, Sartori S, Bay B, et al.
Eur J Prev Cardiol
. 2024 Dec;
PMID: 39708370
Aim: Due to the absence of validated bleeding risk tools in cancer patients undergoing percutaneous coronary intervention (PCI), we aimed to validate an adapted version of the Academic Research Consortium...
8.
Gitto M, Leone P, Gioia F, Chiarito M, Latini A, Tartaglia F, et al.
Am J Cardiol
. 2024 Dec;
239:28-35.
PMID: 39667516
Coronary dissection is a potential occurrence after lesion preparation for percutaneous coronary intervention (PCI). Unlike stents, drug-coated balloons (DCBs) do not allow to cover dissections, thus demanding an assessment of...
9.
Stefanini G, Gitto M
G Ital Cardiol (Rome)
. 2024 Nov;
25(11 Suppl 3):3S.
PMID: 39588600
No abstract available.
10.
Di Muro F, Vogel B, Sartori S, Tchetche D, Feng Y, Petronio A, et al.
Am J Cardiol
. 2024 Nov;
236():56-63.
PMID: 39522578
Limited evidence exists concerning the prognostic impact of baseline left ventricular ejection fraction (LVEF) on outcomes among women undergoing transcatheter aortic valve implantation (TAVI), which we aimed to investigate in...